SCHEMBL689217

SCHEMBL689217

Nc1cccc(O)c1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.70
CA1 P00915 4/20 0.70
CA2 P00918 4/20 0.70
CA7 P43166 4/20 0.70
CA9 Q16790 4/20 0.70
CA14 Q9ULX7 4/20 0.70
G6PD P11413 1/20 0.52
CASP7 P55210 1/20 0.52
CASP6 P55212 1/20 0.52
MMP2 P08253 1/20 0.52
THRB P10828 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
BID P55957 4/20 0.43
MCL1 Q07820 4/20 0.43
BCL2L1 Q07817 3/20 0.43
BAK1 Q16611 3/20 0.43
KAT8 Q9H7Z6 2/20 0.43
PPARG P37231 1/20 0.43
PPARA Q07869 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29409634 1.00 CA12 (0.70) CA12CA1CA2CA7CA9
Methylamine SCHEMBL7126522 0.96 CA12 (0.64) CA12CA1CA2CA7CA9
Salicylic Acid SCHEMBL28686792 0.89 ALDH1A1 (0.64) CA12CA1CA2CA7CA9
SCHEMBL1000014 0.85 MMP2 (0.54) CA12CA1CA2CA7CA9
Mesalamine SCHEMBL21647323 0.83 KDM4E (0.69) CA12CA1CA2CA7CA9
SCHEMBL5603402 0.83 CA1 (1.00) CA12CA1CA2CA7CA9
SCHEMBL224031 0.83 CA1 (1.00) CA12CA1CA2CA7CA9
SCHEMBL2890578 0.82 CA12 (0.50) CA12CA1CA2CA7CA9
SCHEMBL18043789 0.81 MMP2 (0.50) CA12CA1CA2CA7CA9
SCHEMBL11869293 0.81 MAPT (0.57) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1038 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3999671-B1 COMPOSITIONS AND METHODS FOR METAL PRE-TREATMENT CHEMETALL GMBH (DE) 2025-04-02 EP claimed
US-12195575-B2 Compositions and methods for metal pre-treatment CHEMETALL GMBH (DE) 2025-01-14 US claimed
CN-113015935-B Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same 日产化学株式会社 2024-12-13 CN claimed
CN-118831211-A Lubricating coating with anti-hyperplasia effect and preparation method thereof 四川大学华西医院 2024-10-25 CN claimed
CN-118593783-A Super hydrophilic coating with anticoagulation anti-inflammatory performance and preparation method thereof 四川大学华西医院 2024-09-06 CN claimed
CN-118576785-A Super-lubricating coating with super-hydrophobic performance and preparation method thereof 四川大学华西医院 2024-09-03 CN claimed
CN-114096581-B Composition and method for pretreatment of metals 凯密特尔有限责任公司 2024-07-12 CN claimed
US-20220289892-A1 COMPOSITIONS AND METHODS FOR METAL PRE-TREATMENT CHEMETALL GMBH (DE) 2022-09-15 US claimed
EP-3999671-A1 COMPOSITIONS AND METHODS FOR METAL PRE-TREATMENT Chemetall GmbH (DE) 2022-05-25 EP claimed
CN-114096581-A Compositions and methods for metal pretreatment 凯密特尔有限责任公司 2022-02-25 CN claimed
WO-2019173797-A1 PROCESSES FOR THE PRODUCTION OF TRYPTAMINES NEW ATLAS BIOTECHNOLOGIES LLC (US) 2019-09-12 WO claimed
CN-110129804-A For magnesium or the corrosion inhibitor composition of magnesium alloy 亥姆霍兹中心盖斯特哈赫特材料及海岸研究中心有限公司 2019-08-16 CN claimed
US-20180320271-A1 CORROSION INHIBITOR COMPOSITION FOR MAGNESIUM OR MAGNESIUM ALLOYS Helmholtz-Zentrum Geesthacht Zentrum für Material-und Küstenforschung GmbH (DE) 2018-11-08 US claimed
CN-108291316-A CORROSION INHIBITOR COMPOSITION FOR MAGNESIUM OR MAGNESIUM ALLOYS 亥姆霍兹中心盖斯特哈赫特材料及海岸研究中心有限公司 2018-07-17 CN claimed
EP-1630605-B1 PHOTOSENSITIVE RESIN COMPOSITION TORAY INDUSTRIES (JP) 2017-10-11 EP claimed
WO-2017064185-A1 CORROSION INHIBITOR COMPOSITION FOR MAGNESIUM OR MAGNESIUM ALLOYS Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH (DE) 2017-04-20 WO claimed
EP-1386660-B1 Isolation of immunoglobulins UPFRONT CHROMATOGRAPHY AS (DK) 2009-09-02 EP claimed
EP-2095873-A1 Isolation of immunoglobulins UPFRONT CHROMATOGRAPHY A/S (DK) 2009-09-02 EP claimed
US-7572459-B2 Prevention infections in humans, animals STARPHARMA PTY LTD. (AU) 2009-08-11 US claimed
US-20030129158-A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions STARPHARMA LIMITED 2003-07-10 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030129158-A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions FUT6, B3GNT2, SIGLEC7 CA12 960/4885CA1 2006/4885CA2 1974/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.